Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New contract for DOF

The DOF Group is pleased to announce that PSV Skandi Aukra has been awarded a long term contract by Chrysaor. The charter will commence in December 2020, in direct continuation of its current contract, for a duration of 2 years firm, plus 2 x 1 year options.  Skandi Aukra is a large modern PSV, which has been continuously supporting UKCS Operators, including Chrysaor, for several years, and the DOF Group is delighted to continue its partnership with a key UK client. Contact:CEO Mons S. Aase, Tel +47 91 66 10 12 CFO Hilde Drønen, Tel +47 91 66 10 09

Interim Report Q3, January-September 2020

July – September 2020 · Net sales decreased to SEK 421 million (520) · Operating profit before depreciation decreased to SEK 23 million (29) · Operating profit decreased to SEK 3 million (6) · Earnings after tax amounted to SEK -8 million (-8) · Earnings per share amounted to SEK -0.04 (-0.04) · Cash flow after investing activities amounted to SEK 4 million (-7) January – September 2020 · Net sales decreased to SEK 1,338 million (1,598) · Operating profit before depreciation decreased to SEK 56 million (84) · Operating profit decreased to SEK -11 million (

Ideagen Signs Deal with Leading Cancer Treatment Company

Leading global provider of software products to companies operating in highly regulated industries, Ideagen Plc, has announced a new customer for Qualsys, the eQMS product which is now part of the Q-Pulse suite of products.Blaze Bioscience, The Tumor Paint Company®, formed in 2010 in Seattle, is a privately held biotechnology company that is developing leading edge products for the treatment of cancer. The company’s co-founder, Dr Jim Olson, a paediatric neuro-oncologist at Fred Hutchinson Cancer Research Centre and Seattle Children’s Hospital, is an inventor and pioneer of a revolutionary

Convincing results for Aegirbio's coronavirus test in Italian-Swedish study

The quick and easy test for virus in saliva that Aegirbio offers following the acquisition of Viraspec has been evaluated in two studies, with positive results.The studies were conducted at Linköping University and the hospital of Pescara, Italy. In the studies, the saliva test was compared with PCR – the current gold standard for detection of virus. Aegirbio's test could detect the presence of virus in every PCR-positive sample, and every sample identified as negative by PCR, i.e., without virus, was negative with the Aegirbio test as well. "Together with qualified partners, we have

Divestment of Three Scandinavia’s telecom tower business and assets

Patricia Industries, a part of Investor AB, has agreed to divest its 40 percent share of Three Scandinavia’s tower business and assets by: · Transferring its share of Three Scandinavia’s passive network infrastructure assets to CKH Networks, an operator of CK Hutchison’s European tower business with assets in Austria, Denmark, Ireland, Italy, Sweden and the United Kingdom. · Participating in the divestment of CKH Networks for EUR 10bn to Cellnex, the leading European independent operator of wireless telecommunications infrastructure. The consideration attributable to Patricia

Major increase in spruce bark beetle damage in already affected areas

A late summer swarming caused a widespread spruce bark beetle outbreak and Södra now sees a significant increase in damage. An inventory in late October shows a 25-percent increase in the volume of damaged forest compared with the inventory in late August. Removing as many infested trees as possible before the spring swarming starts is now critical.The most recent damage inventory of Södra’s 330 surveillance estates in late October shows that more than 1.4 million m³sub of spruce forest on members’ estates is spruce bark beetle-impacted. That is about 25 percent, or 300,000 m³sub, more than

iLOQ involved in the new H building construction project

Bothnia High 5 alliance material bank The iLOQ 5 Series digital locking and access control solution will be installed in Vaasa Hospital District’s new H building. The new H building will be built in connection with the Vaasa Central Hospital in Hietalahti. The area of the H building will be approximately 37,000 square meters. The building will have 10 floors and an additional technical space. A safe environment and healthy facilities will be built for the hospital's customers and staff. When completed, the H building will be an intelligent hospital with modern and high-

NCC’s Extraordinary General Meeting, 2020

At today’s Extraordinary General Meeting, NCC’s shareholders resolved in accordance with the motion of the Board of Directors to pay a dividend of SEK 2.50 per share for the 2019 fiscal year.The record date for receiving a dividend was set at November 16, 2020, and payment of the dividend from Euroclear Sweden AB is expected on November 19, 2020. In addition, a resolution on an amendment to the Articles of Association was passed that enables the company to conduct general meetings through postal voting and/or the collection of proxies.  The minutes with a complete list of the

Interim Report Q3, 2020

Third quarter 2020Figures for 2020 and 2019 refer to the Group. · Other operating income amounted to KSEK 1,656 (692) · Result after taxes amounted to KSEK -2,348 (-3,054) · Basic and diluted earnings per share: SEK -0.02 (-0.04) · The cash flow from operating activities was KSEK -5,300 (-3,072 Nine months, Jan-Sep 2020Figures for 2020 and 2019 refer to the Group. · Other operating income amounted to KSEK 3,713 (2,005) · Result after taxes amounted to KSEK -10,942 (-9,979) · Basic and diluted earnings per share: SEK -0.12 (-0.12) · The cash flow from

AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company has received approval from the regulatory authorities in Sweden to initiate a clinical Phase I study with the drug candidate ACD856.The Phase I study is AlzeCure's second clinical study with ACD856, the lead drug candidate within the company’s NeuroRestore platform, which is developed as a symptom-relieving treatment for disease states

Stena Line charts 25 years of success in Belfast

Stena Line is celebrating the 25[th] anniversary (12 Nov 2020) of the relocation of its ferry services to Belfast from Larne in 1995.  During this time, the Irish Sea’s leading ferry company has achieved a number of key milestones including transporting in excess of 33 million passengers, 7 million cars and almost 7 million freight units.When Stena Line established its Belfast operation on 12[th] November 1995, it operated just three ferries to one port in Scotland.  Today, that service has significantly expanded to include seven vessels operating year-round services to Cairnryan,

Scandinavian central banks in new cooperation

The central banks of Denmark, Norway and Sweden have entered into a new agreement regarding principles for central bank currency swap facilities to strengthen contingency for crisis situations and promote financial stability in the region.The agreement establishes the principles for cooperation by the central banks to swap their own currencies with one another, for example if one or more banks, in an extraordinary situation, were to need liquidity in another Scandinavian currency than their home currency. The agreement is the result of discussions taking place among the Scandinavian

New study: Krill astaxanthin oil enhances growth and survival of shrimp in post-larval stage

While previous studies confirmed the stimulating effects of astaxanthin krill oil on Pacific whiteleg shrimp juveniles, little is known about its effect on shrimp in the post-larval stage. A new study from Instituto de Ciências do Mar, Brazil (Labomar) and Aker BioMarine aimed to remedy this knowledge gap, analyzing how astaxanthin krill oil impacts the shrimp during this intermediary growth stage. The team of scientists concluded that astaxanthin krill oil can result in a significant advantage for the Pacific whiteleg shrimp in the post-larval stage. Through the use of growth-enhancing

Changes in Delete Group Oyj's Management Team

Delete Group Oyj | Stock Exchange Release 12 November 2020 at 12:00 (EET)Delete Group has appointed from within the organization Henri Pesonen (M. Sc. Econ., born -82), and Raimo Huhtala (B. Eng., Electrical engineering, born -61) as new members of Delete’s Management Team. Composition of the Group Management Team as of 12 November, 2020: · Tommi Kajasoja, CEO · Ville Mannola, CFO · Janika Vilkman, General Counsel · Henri Pesonen, Business Area Director, Recycling Services · Raimo Huhtala, Business Area Director, Cleaning Services, Finland · Peter Revay, Business Area

Ahlstrom-Munksjö introduces FibRoc®, a new product platform of high performance solutions for durable applications

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE, November 12, 2020 at 12:00 EET  Ahlstrom-Munksjö reinforces its leading position in high performance solutions for durable applications, by launching Ahlstrom-Munksjö FibRoc®. The Fibroc® platform will bring together a wide range of high performance products under the same brand, making it easier for business partners to recognize and understand the offering across the value chain.  “Thanks to its unique know-how and very wide technological platform, Ahlstrom-Munksjö has been able to create, throughout the years, an extensive range of high

Company Announcement 12 / 20 New Strategic Talent Development Programme

Launch of Astralis Talent – New Strategic Talent Development ProgrammeAstralis Group launches a new, strategic talent development programme in Counter-Strike and League of Legends to secure a stronger position within the vast Danish talent pool and in the growing international transfer market. Contributing to the development of players for the A-team will ultimately save transfer costs and we see a strong, long term potential in the growing international market for the sale of contractual player rights. By investing in a talent development programme, we aim to establish a new, increased

Finland’s largest dental care chain relies on Planmeca Romexis® dental imaging solution

Easy image handling and storage is essential to a smooth workflow at the dental office. However, for larger multi-site clinic chains, it’s not always that simple. Systems vary, data is stored on multiple servers and different software solutions just won’t talk to each other. So how can clinic chains be sure that their patient images are accessible both reliably and in real time – at every single clinic? In October 2019, Oral Hammaslääkärit were asking themselves the same question. Oral is the largest private dental care chain in Finland, with close to 70 clinics all across the

Heimstaden Bostad successfully prices its inaugural Green senior unsecured bond

Heimstaden Bostad AB yesterday successfully priced its inaugural Green senior unsecured bond (“Green bond”) with a notional amount of SEK 1,200 million. In connection with the transaction, a NOK senior unsecured bond was also priced with a notional amount of NOK 800 million. Both bonds were offered with fixed and floating rate coupons maturing in February 2025. The transaction attracted significant interest among investors and was heavily oversubscribed. The proceeds from the Green bond issuance will be used in accordance with Heimstaden Bostad’s Green Bond Framework dated October 2019,

Smartoptics announces the DCP-R family of ROADMs for flexible open line systems

Oslo, Norway– November 12, 2020 – Smartoptics, a leading provider of optical networking solutions, today announced the DCP-R family of DWDM ROADMs for flexible open line systems. With the DCP-R family Smartoptics addresses a new market of advanced and reconfigurable optical ring and mesh networks, typically used by network operators and service providers. The ROADMs are designed for use of the new PAM4 and 400ZR traffic formats mixed with legacy protocols, such as Ethernet and Fibre Channel, thereby greatly simplifying optical network planning and service flexibility in edge and metro/

Invitation to webcast

In connection to the interim results of the clinical study SPAGOPIX-01, the company invites to a live webcast today at 13:00. CEO Mats Hansen will present and comment the results, and provide opportunity for questions. The webcast can be reached by: https://www.finwire.tv/webcast/spago-nanomedical/q3/. The webcast will be available afterwards at the home page of Spago Nanomedical. For further information, please contact: Mats Hansen, CEO Spago Nanomedical AB (publ), +46 46 811 88, mats.hansen@spagonanomedical.se

Early-life events linked to lung health in young adulthood

Early-life events, such as the exposure to air pollutants, increases the risk of chronic lung disease in young adulthood, according to new results by researchers at Karolinska Institutet, Sweden, published in the European Respiratory Journal and Thorax. The studies add to the growing evidence that chronic lung disease in adulthood can be traced back to childhood.Chronic bronchitis and chronic obstructive pulmonary disease (COPD), with the hallmark features phlegm and irreversible airflow limitation, respectively, are lung diseases known to affect adults with a history of long-term smoking.

Distinct images in clinical study with SpagoPix

Interim results from the phase I study SPAGOPIX-01 show that SN132D provides MRI contrast enhancement in breast tumors. In line with previous preclinical data the clinical results confirm accumulation of the unique nanomaterial in solid tumors. In addition, unexpectedly good contrast in the pancreas has been observed in all images from the study so far, representing an opportunity the company will explore further.Spago Nanomedical CEO Mats Hansen will provide comments on the results in a webcast, today at 1 pm, which can be reached by the following link: https://www.finwire.tv/webcast/spago-

NCC signs contract for Liseberg’s new water park

NCC and Liseberg amusement park have signed a contract for the construction of a new water park. The assignment is through the development company Liseberg Skår AB and the order value is approximately SEK 700 million. Illustration: Oceana's entrance, Quarry FoldThe assignment is part of NCC’s partnering agreement with Liseberg, which began in 2018. Around one year ago, construction started of Liseberg Grand Curiosa Hotel, the first part of Liseberg’s expansion plans for a destination hotel and water park. Now construction of the water park, Oceana, is also underway. “It will

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top